EMILY WEIBEL: Open Payments
NPI 1730781915 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 40 payments from 10 companies in 2025. Trend: 2023 $2,576 · 2024 $2,233 · 2025 $1,585
Speaker / faculty: $805Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $970 |
| Galderma Laboratories, L.P. | 4 | $143 |
| UCB, Inc. | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| PFIZER INC. | 2 | $46 |
| Amgen Inc. | 2 | $38 |
| Dexcom, Inc. | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
Products named: Bimzelx, ORENCIA, BENLYSTA, PREVNAR 20, Dexcom G6 Transmitter, ACTHAR, BREZTRI, SAPHNELO.
Industry payments across MA — which companies pay providers there.
